Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26023953 | 0.91 | ACACB (0.33) | ARSCN9A | |
| SCHEMBL26030211 | 0.90 | SCN9A (0.33) | ARSCN9A | |
| SCHEMBL25905093 | 0.89 | PDK2 (0.34) | ARSCN9A | |
| SCHEMBL25904918 | 0.89 | PDK2 (0.34) | ARSCN9A | |
| SCHEMBL25905002 | 0.89 | PDK2 (0.34) | ARSCN9A | |
| SCHEMBL26042301 | 0.88 | AR (0.31) | ARSCN9A | |
| SCHEMBL31349526 | 0.82 | AR (0.32) | AR | |
| SCHEMBL25315840 | 0.81 | CA12 (0.38) | SCN9A | |
| SCHEMBL31349563 | 0.81 | AR (0.32) | AR | |
| SCHEMBL26022450 | 0.80 | MAP3K12 (0.32) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743078-A2 | APOL1 INHIBITORS AND METHODS OF USE | Maze Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025015104-A2 | APOL1 INHIBITORS AND METHODS OF USE | MAZE THERAPEUTICS, INC. (US) | 2025-01-16 | — | — | WO | disclosed |